Skip to main content

Liquid Biopsy in Breast Cancer

Participating journal: Breast Cancer Research and Treatment
Liquid biopsy, the analysis of circulating markers in the blood of cancer patients, is a fast-moving research space. There is tremendous excitement for the clinical adoption of liquid biopsy given the potential for it to revolutionise cancer screening, including breast cancer screening. In this collection, we welcome studies investigating the diverse range of circulating markers - such as circulating DNA (ctDNA), circulating tumour cells and exosomes - for breast cancer diagnosis and treatment.

Participating journal

Submit your manuscript to this collection through the participating journal.

Articles

Showing 1-12 of 12 articles